Malignant mesothelioma: recent data on nintedanib and checkpoint inhibitors
Malignant mesothelioma: recent data on nintedani
Approaching squamous-cell carcinoma in a targeted manner
Approaching squamous-cell carcinoma in a targete
Immunotherapy: novel biomarkers on the horizon & news from pivotal trials
Immunotherapy: novel biomarkers on the horizon &
Taking anti-EGFR drug treatment further: later lines
Taking anti-EGFR drug treatment further: later l
“We are making steady progress toward better lung cancer control”
“We are making steady progress toward better lun
EGFR TKI therapy in specific populations and settings
EGFR TKI therapy in specific populations and set
What is new in surgery? Redefining current options
What is new in surgery? Redefining current optio
Preface – WCLC 2017
Preface – WCLC 2017 Fred R. Hirsch, MD, PhD
Multiple approaches for the treatment and prevention of CNS metastases
Multiple approaches for the treatment and preven
Substantial reduction in lung cancer mortality using volume CT screening: the NELSON trial
Substantial reduction in lung cancer mortality u
